These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 11914994

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
    Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, Lavi I, Stamm W, Israeli Urinary Tract Infection Group.
    Clin Infect Dis; 2002 May 01; 34(9):1165-9. PubMed ID: 11941541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro resistance of E coli to TMP/SMX and clinical failure.
    Postgrad Med; 2001 Aug 01; 110(2 Suppl):9-10; discussion 26-7. PubMed ID: 19667570
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
    Allen UD, MacDonald N, Fuite L, Chan F, Stephens D.
    CMAJ; 1999 May 18; 160(10):1436-40. PubMed ID: 10352632
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
    Harding GK, Ronald AR, Boutros P, Lank B.
    Can Med Assoc J; 1975 Jun 14; 112(13 Spec No):9-12. PubMed ID: 1093658
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O, Onur O, Erdede M, Denizbasi A.
    J Emerg Med; 2009 May 14; 36(4):338-41. PubMed ID: 18325714
    [Abstract] [Full Text] [Related]

  • 13. [Antibiotic resistance among E. coli isolates from urinary tract infections (1999-2000): a multicenter study].
    Smaoui H, Mahjoubi F, Boutiba I, Jouaihia W, Thabet L, Znazen A, Kammoun A, Mezghanni S, Triki O, Hammami A, Ben Hassen A, Kechrid A, Ben Redjeb S.
    Tunis Med; 2003 Jun 14; 81(6):390-4. PubMed ID: 14534944
    [Abstract] [Full Text] [Related]

  • 14. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE, Rensimer ER, DuPont HL.
    N Engl J Med; 1982 Jan 21; 306(3):130-5. PubMed ID: 7033781
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dissemination of clonal groups of uropathogenic Escherichia coli is not a significant contributor to trimethoprim and sulfamethoxazole resistance in Galway, Ireland.
    Morris D, Ni Chulain M, Cormican M.
    Int J Antimicrob Agents; 2007 Jul 21; 30(1):97-8. PubMed ID: 17459666
    [No Abstract] [Full Text] [Related]

  • 18. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.
    Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW.
    N Engl J Med; 2001 Oct 04; 345(14):1007-13. PubMed ID: 11586952
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.